About NGX
NGX is a company based in London (United Kingdom) founded in 2016 by Hugo Jones and Jeremy Poland. It operates as a Direct-to-Consumer (D2C), Subscription Services, and HealthTech. NGX has raised $1.58 million across 4 funding rounds. The company has 5 employees as of March 31, 2022. NGX offers products and services including NGX BodyFuel Pro and NGX Genetic Health Tests. NGX operates in a competitive market with competitors including Everlywell, Viome, Color, Invitae and Counsyl, among others.
- Headquarter London, United Kingdom
- Employees 5 as on 31 Mar, 2022
- Founders Hugo Jones, Jeremy Poland
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Nutri-Genetix
-
Annual Revenue
Not available
-
Net Profit
-$282.41 K (USD)0as on Aug 31, 2022
-
EBITDA
Not available
-
Total Equity Funding
$1.58 M (USD)
in 4 rounds
-
Latest Funding Round
$186.04 K (USD), Seed
Feb 23, 2023
-
Investors
Not available
-
Employee Count
5
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NGX
NGX offers a comprehensive portfolio of products and services, including NGX BodyFuel Pro and NGX Genetic Health Tests.
Personalised breakfast shake tailored to individual DNA needs.
Tests for biological age, disease risk, and nutrients.
People of NGX
Unlock access to complete
Unlock access to complete
Funding Insights of NGX
NGX has successfully raised a total of $1.58M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $186.04 thousand completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by NGX
Investment portfolio details for NGX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NGX
Detailed financials for NGX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ngx Comparisons
Peer comparison for NGX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NGX
NGX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Everlywell, Viome, Color, Invitae and Counsyl, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
At-home health tests for biomarkers, nutrition, and hormone analysis.
|
|
| Locked | Locked | Locked |
Machine learning-based bioinformatics solutions for health insights are provided.
|
|
| Locked | Locked | Locked |
Cancer care is delivered through a virtual clinic by Color.
|
|
| Locked | Locked | Locked |
Home-based genetic tests for detecting diseases are provided to individuals.
|
|
| Locked | Locked | Locked |
DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening
|
|
| Locked | Locked | Locked |
Personalized therapeutics are developed using genomic data for rare diseases.
|
Detailed competitors of NGX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ngx
Complete news archive for NGX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NGX
NGX was founded in 2016 and raised its 1st funding round 3 years after it was founded.
NGX is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Hugo Jones is the current CEO of NGX. They have also founded this company.
NGX is a funded company, having raised a total of $1.58M across 4 funding rounds to date.
As of Mar 31, 2022, the latest employee count at NGX is 5.
Personalised nutrition solutions are provided by NGX through genetically tailored breakfast shakes and a range of genetic health tests. Focus is placed on individual DNA insights to optimise nutrient intake for health, longevity, and performance. Sectors include health and wellness with an emphasis on nutrition and biotechnology for genetic testing. Solutions such as NGX BodyFuel Pro and various tests for biological age, disease risk, and nutrient absorption are developed to support immunity, reduce body fat, and enhance overall well-being.
NGX's top competitors include Viome, Variant Bio and Newtopia.
NGX offers NGX BodyFuel Pro and NGX Genetic Health Tests.
The valuation of NGX is $11.09M as of Feb 2023.